NTT Docomo Ventures has invested in Validic, Inc. to enhance its digital healthcare services through a partnership focused on the 'd Healthcare' application.

Information on the Target

Validic, Inc. is a leading healthcare technology company that specializes in providing digital health solutions. The firm focuses on enabling healthcare systems to integrate and manage patient data through its innovative platform, which connects various health applications, devices, and services.

The company aims to improve health outcomes by facilitating seamless data sharing between patients and healthcare providers. Through its services, Validic seeks to empower individuals to take control of their healthcare journey and enhance the overall patient experience.

Industry Overview in Japan

The healthcare technology industry in Japan has been experiencing significant growth in recent years, driven by the increasing need for patient-centered solutions and

View Source

Similar Deals

Otsuka Pharmaceutical Co., Ltd. 4D Molecular Therapeutics

2025

Strategic Partnership Bio Therapeutic Drugs Japan
Blackstone CMIC Co., Ltd.

2025

Strategic Partnership Healthcare Facilities & Services (NEC) Japan
Wontech SheepMedical

2025

Strategic Partnership Medical Equipment, Supplies & Distribution (NEC) Japan
KYORIN Pharmaceutical BIODOL Therapeutics

2025

Strategic Partnership Proprietary & Advanced Pharmaceuticals Japan
日本産業推進機構グループ (NSSK) 株式会社キート (Kito Co., Ltd.)

2023

Strategic Partnership Residential & Long-Term Care Japan
Fujimoto Pharmaceutical Corporation Emcitate

2023

Strategic Partnership Proprietary & Advanced Pharmaceuticals Japan

NTT Docomo Ventures

invested in

Validic, Inc.

in 2023

in a Strategic Partnership deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert